PL2793942T3 - Nowe kompozycje farmaceutyczne zawierające przeciwciało, które wiąże ludzki receptor hormonu antymüllerowskiego typu ii - Google Patents
Nowe kompozycje farmaceutyczne zawierające przeciwciało, które wiąże ludzki receptor hormonu antymüllerowskiego typu iiInfo
- Publication number
- PL2793942T3 PL2793942T3 PL12819106T PL12819106T PL2793942T3 PL 2793942 T3 PL2793942 T3 PL 2793942T3 PL 12819106 T PL12819106 T PL 12819106T PL 12819106 T PL12819106 T PL 12819106T PL 2793942 T3 PL2793942 T3 PL 2793942T3
- Authority
- PL
- Poland
- Prior art keywords
- binds
- antibody
- pharmaceutical compositions
- human anti
- hormone receptor
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2869—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against hormone receptors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
- A61K31/282—Platinum compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/243—Platinum; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
- A61K39/3955—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against proteinaceous materials, e.g. enzymes, hormones, lymphokines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
- A61K39/39558—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against tumor tissues, cells, antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
- C07K16/3069—Reproductive system, e.g. ovaria, uterus, testes, prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
- C07K2317/92—Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Endocrinology (AREA)
- Biomedical Technology (AREA)
- Oncology (AREA)
- Neurology (AREA)
- Inorganic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Reproductive Health (AREA)
- Cell Biology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR1162424A FR2984750B1 (fr) | 2011-12-23 | 2011-12-23 | Nouvelles compositions pharmaceutiques comprenant un anticorps liant le recepteur humain de l'hormone anti-mullerienne de type ii |
EP12819106.1A EP2793942B1 (fr) | 2011-12-23 | 2012-12-21 | Nouvelles compositions pharmaceutiques comprenant un anticorps liant le recepteur humain de l'hormone anti-mullerienne de type ii |
PCT/FR2012/053067 WO2013093379A1 (fr) | 2011-12-23 | 2012-12-21 | Nouvelles compositions pharmaceutiques comprenant un anticorps liant le recepteur humain de l'hormone anti-mullerienne de type ii |
Publications (1)
Publication Number | Publication Date |
---|---|
PL2793942T3 true PL2793942T3 (pl) | 2020-11-16 |
Family
ID=47628323
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL12819106T PL2793942T3 (pl) | 2011-12-23 | 2012-12-21 | Nowe kompozycje farmaceutyczne zawierające przeciwciało, które wiąże ludzki receptor hormonu antymüllerowskiego typu ii |
Country Status (8)
Country | Link |
---|---|
US (2) | US9511138B2 (pl) |
EP (1) | EP2793942B1 (pl) |
JP (1) | JP6134333B2 (pl) |
ES (1) | ES2806073T3 (pl) |
FR (1) | FR2984750B1 (pl) |
PL (1) | PL2793942T3 (pl) |
PT (1) | PT2793942T (pl) |
WO (1) | WO2013093379A1 (pl) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3331569A1 (en) | 2015-08-07 | 2018-06-13 | Gamamabs Pharma | Antibodies, antibody drug conjugates and methods of use |
EP4368207A2 (en) | 2015-09-02 | 2024-05-15 | The Cleveland Clinic Foundation | Ovarian cancer vaccines |
FR3060394B1 (fr) * | 2016-12-16 | 2019-05-24 | Laboratoire Francais Du Fractionnement Et Des Biotechnologies | Combinaison d'anticorps anti-cd303 et anti-amhrii |
WO2018189379A1 (en) * | 2017-04-14 | 2018-10-18 | Gamamabs Pharma | Amhrii-binding compounds for preventing or treating cancers |
BR112019021495A8 (pt) * | 2017-04-14 | 2023-05-02 | Inst Curie | Compostos de ligação ao amhrii para prevenção ou tratamento de cânceres de pulmão |
JP2020521780A (ja) * | 2017-05-29 | 2020-07-27 | ガママブス ファルマ | 癌関連免疫抑制阻害剤 |
WO2023056927A1 (en) * | 2021-10-08 | 2023-04-13 | Lanova Medicines Development Co., Ltd. | Anti-amhrii antibodies |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
US6808901B1 (en) | 1984-09-03 | 2004-10-26 | Celltech R&D Limited | Production of chimeric antibodies |
US5225539A (en) | 1986-03-27 | 1993-07-06 | Medical Research Council | Recombinant altered antibodies and methods of making altered antibodies |
US5204244A (en) | 1987-10-27 | 1993-04-20 | Oncogen | Production of chimeric antibodies by homologous recombination |
US5202238A (en) | 1987-10-27 | 1993-04-13 | Oncogen | Production of chimeric antibodies by homologous recombination |
IL162181A (en) | 1988-12-28 | 2006-04-10 | Pdl Biopharma Inc | A method of producing humanized immunoglubulin, and polynucleotides encoding the same |
US5530101A (en) | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
FR2641468A1 (fr) | 1989-01-11 | 1990-07-13 | Merieux Inst | Anticorps chimeriques anti-recepteur de l'interleukine-2 humaine, leur preparation et compositions pharmaceutiques les contenant |
EP0571613B1 (en) | 1991-12-13 | 2003-09-17 | Xoma Corporation | Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof |
US5869619A (en) | 1991-12-13 | 1999-02-09 | Xoma Corporation | Modified antibody variable domains |
US5639641A (en) | 1992-09-09 | 1997-06-17 | Immunogen Inc. | Resurfacing of rodent antibodies |
KR20180014881A (ko) * | 2003-05-30 | 2018-02-09 | 제넨테크, 인크. | 항-vegf 항체를 사용한 치료 |
WO2005005615A2 (en) * | 2003-07-08 | 2005-01-20 | Fox Chase Cancer Center | Anti-mullerian inhibiting substance type ii receptor (misiir) immunoconjugates to detect and treat cancer |
KR101385886B1 (ko) | 2005-02-03 | 2014-04-24 | 안티토페 리미티드 | 인간 항체들과 단백질들 |
EP1918304A1 (en) * | 2006-11-02 | 2008-05-07 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Monoclonal antibodies against the human anti-müllerian hormone type II receptor (AMHR-II) |
MX2010005221A (es) * | 2007-11-12 | 2010-09-28 | Bipar Sciences Inc | Tratamiento de cancer de utero y cancer de ovario con un inhibidor de parp solo o en combinacion con agentes antitumorales. |
EP2440203A4 (en) * | 2009-06-04 | 2017-06-07 | The Governors of the University of Alberta | Small molecule inhibitors of polynucleotide kinase/phosphatase. poly(adp-ribose) polymerase and uses thereof |
FR2959994B1 (fr) * | 2010-05-12 | 2012-08-24 | Lfb Biotechnologies | Nouveaux anticorps humanises 12g4 mutes et leurs fragments diriges contre le recepteur humain de l'hormone anti-mullerienne de type ii |
-
2011
- 2011-12-23 FR FR1162424A patent/FR2984750B1/fr active Active
-
2012
- 2012-12-21 ES ES12819106T patent/ES2806073T3/es active Active
- 2012-12-21 WO PCT/FR2012/053067 patent/WO2013093379A1/fr active Application Filing
- 2012-12-21 US US14/367,969 patent/US9511138B2/en active Active
- 2012-12-21 EP EP12819106.1A patent/EP2793942B1/fr active Active
- 2012-12-21 PL PL12819106T patent/PL2793942T3/pl unknown
- 2012-12-21 PT PT128191061T patent/PT2793942T/pt unknown
- 2012-12-21 JP JP2014548166A patent/JP6134333B2/ja active Active
-
2016
- 2016-10-25 US US15/333,519 patent/US10179816B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
PT2793942T (pt) | 2020-07-15 |
EP2793942B1 (fr) | 2020-04-15 |
EP2793942A1 (fr) | 2014-10-29 |
JP6134333B2 (ja) | 2017-05-24 |
FR2984750B1 (fr) | 2014-01-10 |
US20150004156A1 (en) | 2015-01-01 |
US9511138B2 (en) | 2016-12-06 |
US20170101478A1 (en) | 2017-04-13 |
FR2984750A1 (fr) | 2013-06-28 |
JP2015506341A (ja) | 2015-03-02 |
WO2013093379A1 (fr) | 2013-06-27 |
US10179816B2 (en) | 2019-01-15 |
ES2806073T3 (es) | 2021-02-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL290848A (en) | Formulation for anti-antibody alpha 4 in cell 7 | |
IL275038A (en) | Formulation for anti-antibody alpha 4 in cell 7 | |
HK1207316A1 (en) | Anti-prolactin receptor antibody formulations | |
HK1203309A1 (en) | Antibody drug conjugates and related compounds, compositions, and methods | |
HK1193052A1 (zh) | 抗體-藥物綴合物 | |
PL2635604T3 (pl) | Kompozycja przeciwciała PAN-HER | |
PT2793942T (pt) | Novas composições farmacêuticas compreendendo um anticorpo que liga o recetor humano da hormona anti-mulleriana de tipo ii | |
BR112014001274A2 (pt) | composto de hormônio luteinizante, e, composição farmacêutica | |
HK1209758A1 (en) | Fixed dosage regimens for anti-type i interferon receptor (ifnar) antibodies i(ifnar) | |
HK1255877A1 (zh) | 含有抗人tslp受體抗體的藥物組合物 | |
EP2714083A4 (en) | RATIONAL-DESIGNED TYPE II RECEPTOR ANTIBODIES WITH A MULLERIAN-INHIBITABLE SUBSTANCE | |
PL2821416T3 (pl) | Nowe przeciwciało przeciwko ludzkiemu receptorowi IL-23 | |
ZA201105801B (en) | Pharmaceutical composition containing leukotriene receptor antagonist and method for the preparation thereof |